Rayyan June 18, 2026 How to Master the Pharmacovigilance System Master File for Inspection Readiness Pharmacovigilance (PV) inspection outcomes are often shaped before the opening meeting begins. Inspectors typically form… Read More
Rayyan June 18, 2026 Pharmacovigilance in 2026 – What is Expected to Change in the Regulatory Landscape Across Regions? Pharma manufacturers are rapidly launching their products across borders, directly intensifying the burden on safety… Read More
Rayyan June 18, 2026 FDA Vowes Improved Adverse Event Reporting With AEMS The FDA announced today the launch of the FDA Adverse Event Monitoring System (AEMS).1 This new… Read More
Rayyan June 18, 2026 The Future of Explainable AI in Drug Safety: Building Trust and Transparency in Pharmacovigilance Introduction: The Imperative for Transparency in AI-Driven Pharmacovigilance As artificial intelligence becomes deeply embedded in… Read More